Philipps University of Marburg
Also known as: Carmen Schade-Brittinger | Clinical Psychology and Psychotherapy, Department of Psychology, Philipps University Marburg | Clinical Psychology and Psychotherapy Dept. of Psychology, Philipps-University Marburg | COVID ambulance Philipps-University Marburg | Department of Clinical Psychology and Psychotherapy, Philipps-University Marburg, Germany, 35032 | Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg | Dept. of Anesthesia And Intensiv Care Medicine University of Marburg | Dept. of Anesthesia And Intensive Care Medicine University of Marburg | Dept. of Clinical Psychology and Psychotherapy, Philipps-University Marburg, Germany | Director der Klinik fur Innere Medizin mit Schwerpunkt Pneumologie-Universitatsklinikum GieBen und Marburg, D-35043 Marburg, Germany | DRK Kinderklinik Siegen | Germany: University Hospital Giessen and Marburg, Department of Urology | Institute of Behavioral-Therapy and -Medicine at the Philipps University Marburg | Klinikum Kassel GmbH | Klinikum Kassel GmbH, D-34125 Kassel | Philipps-Univeristy of Marburg | Philipps Universität Marburg | Philipps University Marburg | Philipps University Marburg Coordination Centre for Clinical Trials | Philipps-University Marburg, Faculty psychology, department clinical psychology | Philipps-University Marburg, Germany / Global and German Principal Investigator | Philipps University Marburg Medical Center | Philipps University of Marburg, Department of pulmonary rehabilitation | Phillipps University Marburg, Clinic for Psychiatry and Psychotherapy | Universitatsklinikum GieBen und Marburg | Universitätsklinikum Gießen Marburg | Universitätsklinikum Giessen und Marburg (UKGM) | Universitätsklinikum Marburg | University Hospital Marburg | University Hospital Marburg, Marburg, Germany | University Medical Center Gießen and Marburg GmbH | University of Marburg
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1999Last known activity
Jul 1, 2026
Timeline
1520s
- Jan 1, 1527
Philipps University of Marburg— Founded
Drugs by trial phase (52 distinct, 46 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (22 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Alzheimer Disease
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Coronavirus Infections
- Dementia
- Diarrhea
- Enteritis
- Epilepsy
- Fallopian Tube Neoplasms
- Hemorrhagic Fever, Ebola
- Hemorrhagic Fevers, Viral
- Hypertension
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Injury
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Neoplasm Metastasis
- Neuroendocrine Tumors
- Oropharyngeal Neoplasms
- Osteoarthritis
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Paralysis
- Parkinson Disease
- Pneumonia
- Pulmonary Disease, Chronic Obstructive
- Pyelonephritis
- Respiratory Distress Syndrome
- Severe Acute Respiratory Syndrome
- Sleep Initiation and Maintenance Disorders
- Small Cell Lung Carcinoma
- Supranuclear Palsy, Progressive
- Urinary Tract Infections
- Virus Diseases
Recent trials (50)
- NCT07266519Lead sponsorPhase 2Jul 1, 2026
- NCT05668390OfficialPhase 3Oct 1, 2023
- NCT05570110Study directorPhase 1/Phase 2Sep 23, 2022
- NCT05570110Lead sponsorPhase 1/Phase 2Sep 23, 2022
- NCT05570110Reponsible party - principal investigatorPhase 1/Phase 2Sep 23, 2022
- NCT05208294Lead sponsorN/AJan 31, 2022
- NCT05208294Overall official - principal investigatorN/AJan 31, 2022
- NCT05208294Reponsible party - principal investigatorN/AJan 31, 2022
- NCT04895449CollaboratorPhase 1Jul 16, 2021
- NCT04955561Reponsible party - principal investigatorN/AJul 13, 2021
- NCT04849598Overall official - principal investigatorN/AApr 13, 2021
- NCT05950776CollaboratorPhase 2Jan 15, 2021
- NCT04602533Overall official - principal investigatorPhase 2Oct 31, 2020
- NCT04569383CollaboratorPhase 1Oct 5, 2020
- NCT04569877Overall official - principal investigatorPhase 2Sep 24, 2020
Details
- Founded
- Marburg, DE Jan 1, 1527
- Last known activity
- Jul 1, 2026